- Browse Grants
- Addiction and Substance Abuse Grants
Addiction and Substance Abuse Grants
Grants for addiction and substance abuse programs.
Looking for grants to support substance abuse prevention and treatment programs, including drug and alcohol addiction services? The Instrumentl team has compiled a few sample grants to get you headed in the right direction.
Read more about each grant below or start a 14-day free trial to see all addiction and substance abuse grants recommended for your specific programs.
400+ Addiction and substance abuse grants in the United States for your nonprofit
From private foundations to corporations seeking to fund grants for nonprofits.
300+
Addiction and Substance Abuse Grants over $5K in average grant size
39
Addiction and Substance Abuse Grants supporting general operating expenses
200+
Addiction and Substance Abuse Grants supporting programs / projects
Addiction and Substance Abuse Grants by location
Africa
Alabama
Alaska
American Samoa
Arizona
Arkansas
Colorado
Connecticut
Delaware
District of Columbia
Georgia (US state)
Guam
Haiti
Hawaii
Idaho
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
North Dakota
Northern Mariana Islands
Ohio
Oklahoma
Oregon
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Utah
Vermont
Virgin Islands
Washington
West Virginia
Wisconsin
Wyoming
View More
Explore grants for your nonprofit:
Rolling deadline
Centene Charitable Foundation Grants
Centene Charitable Foundation
US $300 - US $500,000
Centene Charitable Foundation
Successful corporate citizenship happens when companies invest in the local organizations that know their communities best. The Centene Foundation works with our local partners on initiatives that focus on inclusion, the whole person and community development.
Vision
Centene’s purpose is transforming the health of the community, one person at a time. The Centene Foundation is an essential part of how we pursue this purpose. We achieve measurable impact for the communities we serve through partnerships and philanthropy efforts that invest in initiatives with holistic approaches to dismantling barriers to health.
Areas of Focus
Reflecting Centene’s commitment to the needs of those who rely on government-sponsored health care and to addressing social determinants of health and health equity, preference will be given to initiatives in three distinct areas of focus.
- Healthcare Access
- Social Services
- Education
Rolling deadline
Hearst Foundations Grants
William Randolph Hearst Foundation
US $30,000 - US $200,000
Hearst Foundations' Mission
The Hearst Foundations identify and fund outstanding nonprofits to ensure that people of all backgrounds in the United States have the opportunity to build healthy, productive and inspiring lives.
Hearst Foundations' Goals
The Foundations seek to achieve their mission by funding approaches that result in:
- Improved health and quality of life
- Access to high quality educational options to promote increased academic achievement
- Arts and sciences serving as a cornerstone of society
- Sustainable employment and productive career paths for adults
- Stabilizing and supporting families
Funding Priorities
The Hearst Foundations support well-established nonprofit organizations that address significant issues within their major areas of interests – culture, education, health and social service – and that primarily serve large demographic and/or geographic constituencies. In each area of funding, the Foundations seek to identify those organizations achieving truly differentiated results relative to other organizations making similar efforts for similar populations. The Foundations also look for evidence of sustainability beyond their support.
Culture
The Hearst Foundations fund cultural institutions that offer meaningful programs in the arts and sciences, prioritizing those which enable engagement by young people and create a lasting and measurable impact. The Foundations also fund select programs nurturing and developing artistic talent.
Types of Support: Program, capital and, on a limited basis, general and endowment support
Education
The Hearst Foundations fund educational institutions demonstrating uncommon success in preparing students to thrive in a global society. The Foundations’ focus is largely on higher education, but they also fund innovative models of early childhood and K-12 education, as well as professional development.
Types of Support: Program, scholarship, capital and, on a limited basis, general and endowment support
Health
The Hearst Foundations assist leading regional hospitals, medical centers and specialized medical institutions providing access to high-quality healthcare for low-income populations. In response to the shortage of healthcare professionals necessary to meet the country’s evolving needs, the Foundations also fund programs designed to enhance skills and increase the number of practitioners and educators across roles in healthcare. Because the Foundations seek to use their funds to create a broad and enduring impact on the nation’s health, support for medical research and the development of young investigators is also considered.
Types of Support: Program, capital and, on a limited basis, endowment support
Social Service
The Hearst Foundations fund direct-service organizations that tackle the roots of chronic poverty by applying effective solutions to the most challenging social and economic problems. The Foundations prioritize supporting programs that have proven successful in facilitating economic independence and in strengthening families. Preference is also given to programs with the potential to scale productive practices in order to reach more people in need.
Types of Support: Program, capital and general support
Applications dueDec 31, 2023
Open Applications: Local Community Grants
Wal Mart Foundation
US $250 - US $5,000
Walmart’s more than 2 million associates are residents, neighbors, friends and family in thousands of communities around the globe. Walmart works to strengthen these communities through both retail business and community giving, and we support and invest in communities through local giving. The following programs have open application processes with specific deadlines for eligibility and consideration.
Local Community Grants
Each year, our U.S. stores and clubs award local cash grants ranging from $250 to $5,000. These local grants are designed to address the unique needs of the communities where we operate. They include a variety of organizations, such as animal shelters, elder services and community clean-up projects.
Areas of Funding
- There are eight (8) areas of funding for which an organization can apply. Please review the areas listed below to ensure your organization’s goals fall within one of these areas.
- Community and Economic Development: Improving local communities for the benefit of low-income individuals and families in the local service area
- Diversity and Inclusion: Fostering the building of relationships and understanding among diverse groups in the local service area
- Education: Providing afterschool enrichment, tutoring or vocational training for low-income individuals and families in the local service area
- Environmental Sustainability: Preventing waste, increasing recycling, or supporting other programs that work to improve the environment in the local service area
- Health and Human Service: Providing medical screening, treatment, social services, or shelters for low-income individuals and families in the local service area
- Hunger Relief and Healthy Eating: Providing Federal or charitable meals/snacks for low-income individuals and families in the local service area
- Public Safety: Supporting public safety programs through training programs or equipment in the local service area
- Quality of Life: Improving access to recreation, arts or cultural experiences for low-income individuals and families in the local service area
Applications dueFeb 1, 2024
Scaife Family Foundation Grant
Scaife Family Foundation
Unspecified amount
NOTE: We have two deadlines for submitting proposals: The first business day in February for our Spring Meeting and the first business day of August for Fall. Submissions should be postmarked on or before either of these two deadlines. We normally only consider grants at our Spring and Fall Meetings, but we accept applications at any time and act upon them as expeditiously as possible.
Scaife Family Foundation Grant
For over 30 years, the most vulnerable members of the community have been supported by the Scaife Family Foundation through charitable funding. Since its inception in 1985, the Foundation has provided more than $150 million in donations for non-profit programs and general operating support.
We aim to help make the world a better place by continuing the legacy of generosity made possible by the Scaife Family. Our primary objective is to match the Foundation with non-profit organizations having similar interest areas and goals.
Mission Statement
The Scaife Family Foundation grant awards will support and develop programs that demonstrate the beneficial interaction between humans and animals, early intervention and prevention in the area of drug and alcohol addiction, and address issues surrounding the health and welfare of women and children.
Funding Priorities
Women and Children
We partner with high-impact organizations that break down barriers and help women and children lead bigger, brighter lives free of violence, addiction or abuse. Among other goals, we promote healthy relationships and social change to support the physical and emotional needs of women and children in crisis.Addiction
Almost 21 million Americans have at least one addiction, yet only 10 percent receive treatment. The most common reasons people don't seek treatment are denial that they have a problem, shame in acknowledging their condition or fear of what treatment and recovery may involve.
We support programs and organizations that eliminate these obstacles and provide addiction prevention, intervention, treatment and recovery. This includes both residential and outpatient facilities that provide additional services like job placement and career counseling.
We also partner with nonprofits who are advancing the field of addiction through research, education and training to help counselors respond more effectively to substance use and related issues. Our funding has also trained thousands of physicians and medical school residents in recognizing and treating addiction, particularly alcoholism.
Animal Welfare
We support organizations that promote animal welfare and provide training for service dogs. We also partner with nonprofits who use the power of the animal-human connection in therapeutic settings to improve lives. This includes equine therapy programs, for example, to help heal adults and children with physical, cognitive and emotional disabilities.
Full proposal dueMar 1, 2024
Dr. Scholl Foundation Grants
Dr Scholl Foundation
US $5,000 - US $25,000
NOTE:
Application forms must be requested each year online prior to submitting an application. When you submit an LOI, a member of the foundation staff will be contacting you within the next five business days regarding the status of your request.
Full applications are due at the "full proposal" deadline above.
The Foundation is dedicated to providing financial assistance to organizations committed to improving our world. Solutions to the problems of today's world still lie in the values of innovation, practicality, hard work, and compassion.
The Foundation considers applications for grants in the following areas:
- Education
- Social Service
- Health care
- Civic and cultural
- Environmental
The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad to give us flexibility in providing grants.
The majority of our grants are made in the U.S. However, like Dr. Scholl, we recognize the need for a global outlook. Non-U.S. grants are given to organizations where directors have knowledge of the grantee.
Full proposal dueMay 1, 2024
Lawrence Foundation Grant
The Lawrence Foundation
More than US $5,000
The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.
The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.
Grant Amount and Types
Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.
General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.
Applications dueMay 11, 2024
Max and Victoria Dreyfus Foundation Grant
Max and Victoria Dreyfus Foundation
US $1,000 - US $20,000
Max and Victoria Dreyfus Foundation Grant
The Foundation will consider requests to support museums, cultural and performing arts programs; schools and hospitals; educational, skills-training and other programs for youth, seniors, and persons with disabilities; environmental and wildlife protection activities; and other community-based organizations and programs.
Applications dueAug 20, 2024
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Up to US $450,000
NOTE: All applications are due by 5:00 PM local time of applicant organization. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.
Applications dueAug 20, 2024
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Up to US $450,000
NOTE: All applications are due by 5:00 PM local time of applicant organization.
The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.
Rolling deadline
Centene Charitable Foundation Grants
Centene Charitable Foundation
US $300 - US $500,000
Centene Charitable Foundation
Successful corporate citizenship happens when companies invest in the local organizations that know their communities best. The Centene Foundation works with our local partners on initiatives that focus on inclusion, the whole person and community development.
Vision
Centene’s purpose is transforming the health of the community, one person at a time. The Centene Foundation is an essential part of how we pursue this purpose. We achieve measurable impact for the communities we serve through partnerships and philanthropy efforts that invest in initiatives with holistic approaches to dismantling barriers to health.
Areas of Focus
Reflecting Centene’s commitment to the needs of those who rely on government-sponsored health care and to addressing social determinants of health and health equity, preference will be given to initiatives in three distinct areas of focus.
- Healthcare Access
- Social Services
- Education
Rolling deadline
Hearst Foundations Grants
William Randolph Hearst Foundation
US $30,000 - US $200,000
Hearst Foundations' Mission
The Hearst Foundations identify and fund outstanding nonprofits to ensure that people of all backgrounds in the United States have the opportunity to build healthy, productive and inspiring lives.
Hearst Foundations' Goals
The Foundations seek to achieve their mission by funding approaches that result in:
- Improved health and quality of life
- Access to high quality educational options to promote increased academic achievement
- Arts and sciences serving as a cornerstone of society
- Sustainable employment and productive career paths for adults
- Stabilizing and supporting families
Funding Priorities
The Hearst Foundations support well-established nonprofit organizations that address significant issues within their major areas of interests – culture, education, health and social service – and that primarily serve large demographic and/or geographic constituencies. In each area of funding, the Foundations seek to identify those organizations achieving truly differentiated results relative to other organizations making similar efforts for similar populations. The Foundations also look for evidence of sustainability beyond their support.
Culture
The Hearst Foundations fund cultural institutions that offer meaningful programs in the arts and sciences, prioritizing those which enable engagement by young people and create a lasting and measurable impact. The Foundations also fund select programs nurturing and developing artistic talent.
Types of Support: Program, capital and, on a limited basis, general and endowment support
Education
The Hearst Foundations fund educational institutions demonstrating uncommon success in preparing students to thrive in a global society. The Foundations’ focus is largely on higher education, but they also fund innovative models of early childhood and K-12 education, as well as professional development.
Types of Support: Program, scholarship, capital and, on a limited basis, general and endowment support
Health
The Hearst Foundations assist leading regional hospitals, medical centers and specialized medical institutions providing access to high-quality healthcare for low-income populations. In response to the shortage of healthcare professionals necessary to meet the country’s evolving needs, the Foundations also fund programs designed to enhance skills and increase the number of practitioners and educators across roles in healthcare. Because the Foundations seek to use their funds to create a broad and enduring impact on the nation’s health, support for medical research and the development of young investigators is also considered.
Types of Support: Program, capital and, on a limited basis, endowment support
Social Service
The Hearst Foundations fund direct-service organizations that tackle the roots of chronic poverty by applying effective solutions to the most challenging social and economic problems. The Foundations prioritize supporting programs that have proven successful in facilitating economic independence and in strengthening families. Preference is also given to programs with the potential to scale productive practices in order to reach more people in need.
Types of Support: Program, capital and general support
Applications dueDec 31, 2023
Open Applications: Local Community Grants
Wal Mart Foundation
US $250 - US $5,000
Walmart’s more than 2 million associates are residents, neighbors, friends and family in thousands of communities around the globe. Walmart works to strengthen these communities through both retail business and community giving, and we support and invest in communities through local giving. The following programs have open application processes with specific deadlines for eligibility and consideration.
Local Community Grants
Each year, our U.S. stores and clubs award local cash grants ranging from $250 to $5,000. These local grants are designed to address the unique needs of the communities where we operate. They include a variety of organizations, such as animal shelters, elder services and community clean-up projects.
Areas of Funding
- There are eight (8) areas of funding for which an organization can apply. Please review the areas listed below to ensure your organization’s goals fall within one of these areas.
- Community and Economic Development: Improving local communities for the benefit of low-income individuals and families in the local service area
- Diversity and Inclusion: Fostering the building of relationships and understanding among diverse groups in the local service area
- Education: Providing afterschool enrichment, tutoring or vocational training for low-income individuals and families in the local service area
- Environmental Sustainability: Preventing waste, increasing recycling, or supporting other programs that work to improve the environment in the local service area
- Health and Human Service: Providing medical screening, treatment, social services, or shelters for low-income individuals and families in the local service area
- Hunger Relief and Healthy Eating: Providing Federal or charitable meals/snacks for low-income individuals and families in the local service area
- Public Safety: Supporting public safety programs through training programs or equipment in the local service area
- Quality of Life: Improving access to recreation, arts or cultural experiences for low-income individuals and families in the local service area
Applications dueFeb 1, 2024
Scaife Family Foundation Grant
Scaife Family Foundation
Unspecified amount
NOTE: We have two deadlines for submitting proposals: The first business day in February for our Spring Meeting and the first business day of August for Fall. Submissions should be postmarked on or before either of these two deadlines. We normally only consider grants at our Spring and Fall Meetings, but we accept applications at any time and act upon them as expeditiously as possible.
Scaife Family Foundation Grant
For over 30 years, the most vulnerable members of the community have been supported by the Scaife Family Foundation through charitable funding. Since its inception in 1985, the Foundation has provided more than $150 million in donations for non-profit programs and general operating support.
We aim to help make the world a better place by continuing the legacy of generosity made possible by the Scaife Family. Our primary objective is to match the Foundation with non-profit organizations having similar interest areas and goals.
Mission Statement
The Scaife Family Foundation grant awards will support and develop programs that demonstrate the beneficial interaction between humans and animals, early intervention and prevention in the area of drug and alcohol addiction, and address issues surrounding the health and welfare of women and children.
Funding Priorities
Women and Children
We partner with high-impact organizations that break down barriers and help women and children lead bigger, brighter lives free of violence, addiction or abuse. Among other goals, we promote healthy relationships and social change to support the physical and emotional needs of women and children in crisis.Addiction
Almost 21 million Americans have at least one addiction, yet only 10 percent receive treatment. The most common reasons people don't seek treatment are denial that they have a problem, shame in acknowledging their condition or fear of what treatment and recovery may involve.
We support programs and organizations that eliminate these obstacles and provide addiction prevention, intervention, treatment and recovery. This includes both residential and outpatient facilities that provide additional services like job placement and career counseling.
We also partner with nonprofits who are advancing the field of addiction through research, education and training to help counselors respond more effectively to substance use and related issues. Our funding has also trained thousands of physicians and medical school residents in recognizing and treating addiction, particularly alcoholism.
Animal Welfare
We support organizations that promote animal welfare and provide training for service dogs. We also partner with nonprofits who use the power of the animal-human connection in therapeutic settings to improve lives. This includes equine therapy programs, for example, to help heal adults and children with physical, cognitive and emotional disabilities.
Full proposal dueMar 1, 2024
Dr. Scholl Foundation Grants
Dr Scholl Foundation
US $5,000 - US $25,000
NOTE:
Application forms must be requested each year online prior to submitting an application. When you submit an LOI, a member of the foundation staff will be contacting you within the next five business days regarding the status of your request.
Full applications are due at the "full proposal" deadline above.
The Foundation is dedicated to providing financial assistance to organizations committed to improving our world. Solutions to the problems of today's world still lie in the values of innovation, practicality, hard work, and compassion.
The Foundation considers applications for grants in the following areas:
- Education
- Social Service
- Health care
- Civic and cultural
- Environmental
The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad to give us flexibility in providing grants.
The majority of our grants are made in the U.S. However, like Dr. Scholl, we recognize the need for a global outlook. Non-U.S. grants are given to organizations where directors have knowledge of the grantee.
Full proposal dueMay 1, 2024
Lawrence Foundation Grant
The Lawrence Foundation
More than US $5,000
The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.
The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.
Grant Amount and Types
Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.
General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.
Applications dueMay 11, 2024
Max and Victoria Dreyfus Foundation Grant
Max and Victoria Dreyfus Foundation
US $1,000 - US $20,000
Max and Victoria Dreyfus Foundation Grant
The Foundation will consider requests to support museums, cultural and performing arts programs; schools and hospitals; educational, skills-training and other programs for youth, seniors, and persons with disabilities; environmental and wildlife protection activities; and other community-based organizations and programs.
Applications dueAug 20, 2024
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Up to US $450,000
NOTE: All applications are due by 5:00 PM local time of applicant organization. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.
Applications dueAug 20, 2024
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Up to US $450,000
NOTE: All applications are due by 5:00 PM local time of applicant organization.
The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.
See more Addiction and Substance Abuse Grants
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.
No credit card required.
Farrell Rouse
Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Addiction and Substance Abuse Grants over $5K in average grant size
Addiction and Substance Abuse Grants supporting general operating expenses
Addiction and Substance Abuse Grants supporting programs / projects


















































Centene Charitable Foundation Grants
Centene Charitable Foundation
Centene Charitable Foundation
Successful corporate citizenship happens when companies invest in the local organizations that know their communities best. The Centene Foundation works with our local partners on initiatives that focus on inclusion, the whole person and community development.
Vision
Centene’s purpose is transforming the health of the community, one person at a time. The Centene Foundation is an essential part of how we pursue this purpose. We achieve measurable impact for the communities we serve through partnerships and philanthropy efforts that invest in initiatives with holistic approaches to dismantling barriers to health.
Areas of Focus
Reflecting Centene’s commitment to the needs of those who rely on government-sponsored health care and to addressing social determinants of health and health equity, preference will be given to initiatives in three distinct areas of focus.
- Healthcare Access
- Social Services
- Education
Hearst Foundations Grants
William Randolph Hearst Foundation
Hearst Foundations' Mission
The Hearst Foundations identify and fund outstanding nonprofits to ensure that people of all backgrounds in the United States have the opportunity to build healthy, productive and inspiring lives.
Hearst Foundations' Goals
The Foundations seek to achieve their mission by funding approaches that result in:
- Improved health and quality of life
- Access to high quality educational options to promote increased academic achievement
- Arts and sciences serving as a cornerstone of society
- Sustainable employment and productive career paths for adults
- Stabilizing and supporting families
Funding Priorities
The Hearst Foundations support well-established nonprofit organizations that address significant issues within their major areas of interests – culture, education, health and social service – and that primarily serve large demographic and/or geographic constituencies. In each area of funding, the Foundations seek to identify those organizations achieving truly differentiated results relative to other organizations making similar efforts for similar populations. The Foundations also look for evidence of sustainability beyond their support.
Culture
The Hearst Foundations fund cultural institutions that offer meaningful programs in the arts and sciences, prioritizing those which enable engagement by young people and create a lasting and measurable impact. The Foundations also fund select programs nurturing and developing artistic talent.
Types of Support: Program, capital and, on a limited basis, general and endowment support
Education
The Hearst Foundations fund educational institutions demonstrating uncommon success in preparing students to thrive in a global society. The Foundations’ focus is largely on higher education, but they also fund innovative models of early childhood and K-12 education, as well as professional development.
Types of Support: Program, scholarship, capital and, on a limited basis, general and endowment support
Health
The Hearst Foundations assist leading regional hospitals, medical centers and specialized medical institutions providing access to high-quality healthcare for low-income populations. In response to the shortage of healthcare professionals necessary to meet the country’s evolving needs, the Foundations also fund programs designed to enhance skills and increase the number of practitioners and educators across roles in healthcare. Because the Foundations seek to use their funds to create a broad and enduring impact on the nation’s health, support for medical research and the development of young investigators is also considered.
Types of Support: Program, capital and, on a limited basis, endowment support
Social Service
The Hearst Foundations fund direct-service organizations that tackle the roots of chronic poverty by applying effective solutions to the most challenging social and economic problems. The Foundations prioritize supporting programs that have proven successful in facilitating economic independence and in strengthening families. Preference is also given to programs with the potential to scale productive practices in order to reach more people in need.
Types of Support: Program, capital and general support
Open Applications: Local Community Grants
Wal Mart Foundation
Walmart’s more than 2 million associates are residents, neighbors, friends and family in thousands of communities around the globe. Walmart works to strengthen these communities through both retail business and community giving, and we support and invest in communities through local giving. The following programs have open application processes with specific deadlines for eligibility and consideration.
Local Community Grants
Each year, our U.S. stores and clubs award local cash grants ranging from $250 to $5,000. These local grants are designed to address the unique needs of the communities where we operate. They include a variety of organizations, such as animal shelters, elder services and community clean-up projects.
Areas of Funding
- There are eight (8) areas of funding for which an organization can apply. Please review the areas listed below to ensure your organization’s goals fall within one of these areas.
- Community and Economic Development: Improving local communities for the benefit of low-income individuals and families in the local service area
- Diversity and Inclusion: Fostering the building of relationships and understanding among diverse groups in the local service area
- Education: Providing afterschool enrichment, tutoring or vocational training for low-income individuals and families in the local service area
- Environmental Sustainability: Preventing waste, increasing recycling, or supporting other programs that work to improve the environment in the local service area
- Health and Human Service: Providing medical screening, treatment, social services, or shelters for low-income individuals and families in the local service area
- Hunger Relief and Healthy Eating: Providing Federal or charitable meals/snacks for low-income individuals and families in the local service area
- Public Safety: Supporting public safety programs through training programs or equipment in the local service area
- Quality of Life: Improving access to recreation, arts or cultural experiences for low-income individuals and families in the local service area
Scaife Family Foundation Grant
Scaife Family Foundation
NOTE: We have two deadlines for submitting proposals: The first business day in February for our Spring Meeting and the first business day of August for Fall. Submissions should be postmarked on or before either of these two deadlines. We normally only consider grants at our Spring and Fall Meetings, but we accept applications at any time and act upon them as expeditiously as possible.
Scaife Family Foundation Grant
For over 30 years, the most vulnerable members of the community have been supported by the Scaife Family Foundation through charitable funding. Since its inception in 1985, the Foundation has provided more than $150 million in donations for non-profit programs and general operating support.
We aim to help make the world a better place by continuing the legacy of generosity made possible by the Scaife Family. Our primary objective is to match the Foundation with non-profit organizations having similar interest areas and goals.
Mission Statement
The Scaife Family Foundation grant awards will support and develop programs that demonstrate the beneficial interaction between humans and animals, early intervention and prevention in the area of drug and alcohol addiction, and address issues surrounding the health and welfare of women and children.
Funding Priorities
Women and Children
We partner with high-impact organizations that break down barriers and help women and children lead bigger, brighter lives free of violence, addiction or abuse. Among other goals, we promote healthy relationships and social change to support the physical and emotional needs of women and children in crisis.Addiction
Almost 21 million Americans have at least one addiction, yet only 10 percent receive treatment. The most common reasons people don't seek treatment are denial that they have a problem, shame in acknowledging their condition or fear of what treatment and recovery may involve.
We support programs and organizations that eliminate these obstacles and provide addiction prevention, intervention, treatment and recovery. This includes both residential and outpatient facilities that provide additional services like job placement and career counseling.
We also partner with nonprofits who are advancing the field of addiction through research, education and training to help counselors respond more effectively to substance use and related issues. Our funding has also trained thousands of physicians and medical school residents in recognizing and treating addiction, particularly alcoholism.
Animal Welfare
We support organizations that promote animal welfare and provide training for service dogs. We also partner with nonprofits who use the power of the animal-human connection in therapeutic settings to improve lives. This includes equine therapy programs, for example, to help heal adults and children with physical, cognitive and emotional disabilities.Dr. Scholl Foundation Grants
Dr Scholl Foundation
NOTE:
Application forms must be requested each year online prior to submitting an application. When you submit an LOI, a member of the foundation staff will be contacting you within the next five business days regarding the status of your request.
Full applications are due at the "full proposal" deadline above.
The Foundation is dedicated to providing financial assistance to organizations committed to improving our world. Solutions to the problems of today's world still lie in the values of innovation, practicality, hard work, and compassion.
The Foundation considers applications for grants in the following areas:
- Education
- Social Service
- Health care
- Civic and cultural
- Environmental
The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad to give us flexibility in providing grants.
The majority of our grants are made in the U.S. However, like Dr. Scholl, we recognize the need for a global outlook. Non-U.S. grants are given to organizations where directors have knowledge of the grantee.
Lawrence Foundation Grant
The Lawrence Foundation
The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.
The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.
Grant Amount and Types
Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.
General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.
Max and Victoria Dreyfus Foundation Grant
Max and Victoria Dreyfus Foundation
Max and Victoria Dreyfus Foundation Grant
The Foundation will consider requests to support museums, cultural and performing arts programs; schools and hospitals; educational, skills-training and other programs for youth, seniors, and persons with disabilities; environmental and wildlife protection activities; and other community-based organizations and programs.
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NOTE: All applications are due by 5:00 PM local time of applicant organization.
The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.Centene Charitable Foundation Grants
Centene Charitable Foundation
Centene Charitable Foundation
Successful corporate citizenship happens when companies invest in the local organizations that know their communities best. The Centene Foundation works with our local partners on initiatives that focus on inclusion, the whole person and community development.
Vision
Centene’s purpose is transforming the health of the community, one person at a time. The Centene Foundation is an essential part of how we pursue this purpose. We achieve measurable impact for the communities we serve through partnerships and philanthropy efforts that invest in initiatives with holistic approaches to dismantling barriers to health.
Areas of Focus
Reflecting Centene’s commitment to the needs of those who rely on government-sponsored health care and to addressing social determinants of health and health equity, preference will be given to initiatives in three distinct areas of focus.
- Healthcare Access
- Social Services
- Education
Hearst Foundations Grants
William Randolph Hearst Foundation
Hearst Foundations' Mission
The Hearst Foundations identify and fund outstanding nonprofits to ensure that people of all backgrounds in the United States have the opportunity to build healthy, productive and inspiring lives.
Hearst Foundations' Goals
The Foundations seek to achieve their mission by funding approaches that result in:
- Improved health and quality of life
- Access to high quality educational options to promote increased academic achievement
- Arts and sciences serving as a cornerstone of society
- Sustainable employment and productive career paths for adults
- Stabilizing and supporting families
Funding Priorities
The Hearst Foundations support well-established nonprofit organizations that address significant issues within their major areas of interests – culture, education, health and social service – and that primarily serve large demographic and/or geographic constituencies. In each area of funding, the Foundations seek to identify those organizations achieving truly differentiated results relative to other organizations making similar efforts for similar populations. The Foundations also look for evidence of sustainability beyond their support.
Culture
The Hearst Foundations fund cultural institutions that offer meaningful programs in the arts and sciences, prioritizing those which enable engagement by young people and create a lasting and measurable impact. The Foundations also fund select programs nurturing and developing artistic talent.
Types of Support: Program, capital and, on a limited basis, general and endowment support
Education
The Hearst Foundations fund educational institutions demonstrating uncommon success in preparing students to thrive in a global society. The Foundations’ focus is largely on higher education, but they also fund innovative models of early childhood and K-12 education, as well as professional development.
Types of Support: Program, scholarship, capital and, on a limited basis, general and endowment support
Health
The Hearst Foundations assist leading regional hospitals, medical centers and specialized medical institutions providing access to high-quality healthcare for low-income populations. In response to the shortage of healthcare professionals necessary to meet the country’s evolving needs, the Foundations also fund programs designed to enhance skills and increase the number of practitioners and educators across roles in healthcare. Because the Foundations seek to use their funds to create a broad and enduring impact on the nation’s health, support for medical research and the development of young investigators is also considered.
Types of Support: Program, capital and, on a limited basis, endowment support
Social Service
The Hearst Foundations fund direct-service organizations that tackle the roots of chronic poverty by applying effective solutions to the most challenging social and economic problems. The Foundations prioritize supporting programs that have proven successful in facilitating economic independence and in strengthening families. Preference is also given to programs with the potential to scale productive practices in order to reach more people in need.
Types of Support: Program, capital and general support
Open Applications: Local Community Grants
Wal Mart Foundation
Walmart’s more than 2 million associates are residents, neighbors, friends and family in thousands of communities around the globe. Walmart works to strengthen these communities through both retail business and community giving, and we support and invest in communities through local giving. The following programs have open application processes with specific deadlines for eligibility and consideration.
Local Community Grants
Each year, our U.S. stores and clubs award local cash grants ranging from $250 to $5,000. These local grants are designed to address the unique needs of the communities where we operate. They include a variety of organizations, such as animal shelters, elder services and community clean-up projects.
Areas of Funding
- There are eight (8) areas of funding for which an organization can apply. Please review the areas listed below to ensure your organization’s goals fall within one of these areas.
- Community and Economic Development: Improving local communities for the benefit of low-income individuals and families in the local service area
- Diversity and Inclusion: Fostering the building of relationships and understanding among diverse groups in the local service area
- Education: Providing afterschool enrichment, tutoring or vocational training for low-income individuals and families in the local service area
- Environmental Sustainability: Preventing waste, increasing recycling, or supporting other programs that work to improve the environment in the local service area
- Health and Human Service: Providing medical screening, treatment, social services, or shelters for low-income individuals and families in the local service area
- Hunger Relief and Healthy Eating: Providing Federal or charitable meals/snacks for low-income individuals and families in the local service area
- Public Safety: Supporting public safety programs through training programs or equipment in the local service area
- Quality of Life: Improving access to recreation, arts or cultural experiences for low-income individuals and families in the local service area
Scaife Family Foundation Grant
Scaife Family Foundation
NOTE: We have two deadlines for submitting proposals: The first business day in February for our Spring Meeting and the first business day of August for Fall. Submissions should be postmarked on or before either of these two deadlines. We normally only consider grants at our Spring and Fall Meetings, but we accept applications at any time and act upon them as expeditiously as possible.
Scaife Family Foundation Grant
For over 30 years, the most vulnerable members of the community have been supported by the Scaife Family Foundation through charitable funding. Since its inception in 1985, the Foundation has provided more than $150 million in donations for non-profit programs and general operating support.
We aim to help make the world a better place by continuing the legacy of generosity made possible by the Scaife Family. Our primary objective is to match the Foundation with non-profit organizations having similar interest areas and goals.
Mission Statement
The Scaife Family Foundation grant awards will support and develop programs that demonstrate the beneficial interaction between humans and animals, early intervention and prevention in the area of drug and alcohol addiction, and address issues surrounding the health and welfare of women and children.
Funding Priorities
Women and Children
We partner with high-impact organizations that break down barriers and help women and children lead bigger, brighter lives free of violence, addiction or abuse. Among other goals, we promote healthy relationships and social change to support the physical and emotional needs of women and children in crisis.Addiction
Almost 21 million Americans have at least one addiction, yet only 10 percent receive treatment. The most common reasons people don't seek treatment are denial that they have a problem, shame in acknowledging their condition or fear of what treatment and recovery may involve.
We support programs and organizations that eliminate these obstacles and provide addiction prevention, intervention, treatment and recovery. This includes both residential and outpatient facilities that provide additional services like job placement and career counseling.
We also partner with nonprofits who are advancing the field of addiction through research, education and training to help counselors respond more effectively to substance use and related issues. Our funding has also trained thousands of physicians and medical school residents in recognizing and treating addiction, particularly alcoholism.
Animal Welfare
We support organizations that promote animal welfare and provide training for service dogs. We also partner with nonprofits who use the power of the animal-human connection in therapeutic settings to improve lives. This includes equine therapy programs, for example, to help heal adults and children with physical, cognitive and emotional disabilities.Dr. Scholl Foundation Grants
Dr Scholl Foundation
NOTE:
Application forms must be requested each year online prior to submitting an application. When you submit an LOI, a member of the foundation staff will be contacting you within the next five business days regarding the status of your request.
Full applications are due at the "full proposal" deadline above.
The Foundation is dedicated to providing financial assistance to organizations committed to improving our world. Solutions to the problems of today's world still lie in the values of innovation, practicality, hard work, and compassion.
The Foundation considers applications for grants in the following areas:
- Education
- Social Service
- Health care
- Civic and cultural
- Environmental
The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad to give us flexibility in providing grants.
The majority of our grants are made in the U.S. However, like Dr. Scholl, we recognize the need for a global outlook. Non-U.S. grants are given to organizations where directors have knowledge of the grantee.
Lawrence Foundation Grant
The Lawrence Foundation
The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.
The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.
Grant Amount and Types
Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.
General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.
Max and Victoria Dreyfus Foundation Grant
Max and Victoria Dreyfus Foundation
Max and Victoria Dreyfus Foundation Grant
The Foundation will consider requests to support museums, cultural and performing arts programs; schools and hospitals; educational, skills-training and other programs for youth, seniors, and persons with disabilities; environmental and wildlife protection activities; and other community-based organizations and programs.
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NOTE: All applications are due by 5:00 PM local time of applicant organization.
The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.See more Addiction and Substance Abuse Grants
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Browse Grants > Addiction and Substance Abuse Grants
Centene Charitable Foundation Grants
Centene Charitable Foundation
Deadline: Rolling
Grant amount: US $300 - US $500,000
Fields of work: Child Welfare Services Education Community Health Education Children With Disabilities Children’s Mental Health Art & Culture Diversity, Equity & Inclusion Youth Services Children’s Health & Pediatrics Health Disparities & Social Determinants of Health Show all
Applicant type: Nonprofit
Funding uses: Project / Program, Education / Outreach, General Operating Expense, Capital Project
Location of project: United States
Location of residency: United States
990 Snapshot
Overview:
Centene Charitable Foundation
Successful corporate citizenship happens when companies invest in the local organizations that know their communities best. The Centene Foundation works with our local partners on initiatives that focus on inclusion, the whole person and community development.
Vision
Centene’s purpose is transforming the health of the community, one person at a time. The Centene Foundation is an essential part of how we pursue this purpose. We achieve measurable impact for the communities we serve through partnerships and philanthropy efforts that invest in initiatives with holistic approaches to dismantling barriers to health.
Areas of Focus
Reflecting Centene’s commitment to the needs of those who rely on government-sponsored health care and to addressing social determinants of health and health equity, preference will be given to initiatives in three distinct areas of focus.
- Healthcare Access
- Social Services
- Education
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
- An organization must represent a U.S. based IRS qualified charitable 501(c)(3) organization with a valid tax ID.
- The Centene Corporation supports:
- Sponsorship Requests that will support events that will benefit your organization
- Charitable Requests for programs, initiatives, campaigns, or general funding
Ineligibility:
- The Foundation does not accept request from:
- Individual person(s) or families
- Political, labor and fraternal organizations
- For-profit publications or organizations seeking advertisements or promotional support
- Religious organizations (i.e. churches or organizations direction tied to a place of worship) as determined at the sole discretion of Centene Corporation
- Sponsorships of local groups/individuals to participate in regional, national or international competitions, conferences or events
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed November 29, 2023 and last updated August 01, 2023
See 100+ more grants like Centene Charitable Foundation Grants
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Hearst Foundations Grants
William Randolph Hearst Foundation
Deadline: Rolling
Grant amount: US $30,000 - US $200,000
Fields of work: Cancer/Oncology Aging/Gerontology Domestic Violence Addiction & Substance Use Disorders STEM Education Teacher Development & Training Diseases & Conditions Job Creation Sexual Assault/Abuse Education - Higher Education Art Education Artist Training & Development Medical Education & Professional Training Literacy Health Care Access & Delivery Workforce Preparation & Job Readiness Academic Scholarship Programs Affordable Housing Youth Development & Leadership Food Delivery & Distribution Services Show all
Applicant type: Nonprofit
Funding uses: Education / Outreach, General Operating Expense, Project / Program, Capital Project, Biomedical, Behavioral
Location of project: United States
Location of residency: United States
990 Snapshot
Overview:
Hearst Foundations' Mission
The Hearst Foundations identify and fund outstanding nonprofits to ensure that people of all backgrounds in the United States have the opportunity to build healthy, productive and inspiring lives.
Hearst Foundations' Goals
The Foundations seek to achieve their mission by funding approaches that result in:
- Improved health and quality of life
- Access to high quality educational options to promote increased academic achievement
- Arts and sciences serving as a cornerstone of society
- Sustainable employment and productive career paths for adults
- Stabilizing and supporting families
Funding Priorities
The Hearst Foundations support well-established nonprofit organizations that address significant issues within their major areas of interests – culture, education, health and social service – and that primarily serve large demographic and/or geographic constituencies. In each area of funding, the Foundations seek to identify those organizations achieving truly differentiated results relative to other organizations making similar efforts for similar populations. The Foundations also look for evidence of sustainability beyond their support.
The Hearst Foundations fund cultural institutions that offer meaningful programs in the arts and sciences, prioritizing those which enable engagement by young people and create a lasting and measurable impact. The Foundations also fund select programs nurturing and developing artistic talent.
Types of Support: Program, capital and, on a limited basis, general and endowment support
The Hearst Foundations fund educational institutions demonstrating uncommon success in preparing students to thrive in a global society. The Foundations’ focus is largely on higher education, but they also fund innovative models of early childhood and K-12 education, as well as professional development.
Types of Support: Program, scholarship, capital and, on a limited basis, general and endowment support
The Hearst Foundations assist leading regional hospitals, medical centers and specialized medical institutions providing access to high-quality healthcare for low-income populations. In response to the shortage of healthcare professionals necessary to meet the country’s evolving needs, the Foundations also fund programs designed to enhance skills and increase the number of practitioners and educators across roles in healthcare. Because the Foundations seek to use their funds to create a broad and enduring impact on the nation’s health, support for medical research and the development of young investigators is also considered.
Types of Support: Program, capital and, on a limited basis, endowment support
The Hearst Foundations fund direct-service organizations that tackle the roots of chronic poverty by applying effective solutions to the most challenging social and economic problems. The Foundations prioritize supporting programs that have proven successful in facilitating economic independence and in strengthening families. Preference is also given to programs with the potential to scale productive practices in order to reach more people in need.
Types of Support: Program, capital and general support
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
- Applicants must be 501(c)(3) organizations and classified as a 509(a)(1), 509(a)(2) or a functionally integrated 509(a)(3).
- We require that all grantees have an annual budget greater than $1,000,000.
- In limited cases, the Foundations fund:
- Endowment grants, provided the organization has an existing endowment with the Hearst Foundations and a track record of strong performance and consistent stewardship.
- Faith-based organizations, provided that the services they offer are inclusive and fit within the Foundations’ guidelines
- Grantee organizations must wait a minimum of three years from their grant award date before the Foundations will consider another request.
Preferences:
- While the Foundations aim to create fulfilling lives for all Americans, they have a particular sense of urgency in addressing the needs of low-income populations.
- Culture Priority Area:
- Preference will be given to:
- Artist development and training
- Arts education programs that effectively fill the void of arts programming in K-12 curricula
- Science education programs that focus on developing academic pathways in science, technology, engineering and math
- Education Priority Area:
- Preference will be given to:
- Higher education programs and scholarships and, on a limited basis, scholarships for post-graduate education
- Professional development for teachers
- Health Priority Area:
- Preference will be given to:
- Professional development
- Programs improving access to high-quality healthcare for low-income populations
- Programs developing and providing specialized care for the complex needs of elderly populations
- Programs scaling innovative healthcare delivery systems to provide efficient, coordinated care
- Research, particularly related to finding new cures and treatments for prevalent diseases, such as cancer
- Social Service Priority Area:
- Preference will be given to:
- Affordable housing
- Job creation and job training
- Literacy
- Youth development
- An organization’s national headquarters for wider initiatives instead of local chapters
- In limited cases the Foundations fund organizations focusing on:
- Domestic abuse
- Food delivery and food banks
- Sexual abuse
- Substance abuse
Ineligibility:
- The Hearst Foundations DO NOT FUND organizations that are:
- based outside of the United States.
- operating with audited expenses less than $2 million.
- undergoing leadership transitions or with new leadership in place for less than one year.
- not registered as 501(c)(3) organizations. An IRS determination letter is required to receive funding.
- Endowment grants, provided the organization has an existing endowment with the Hearst Foundations and a track record of strong performance and consistent stewardship.
- Faith-based organizations, provided that the services they offer are inclusive and fit within the Foundations' guidelines.
- Organizations lacking regional and national support.
- The Hearst Foundations DO NOT FUND proposals for:
- festivals, tours, conferences, workshops or seminars.
- https://www.hearstfdn.org/funding-limitations
- advocacy or public policy research.
- special events, tickets, tables or advertising for fundraising events.
- seed money or pilot programs.
- established programs lacking demonstrable long-term impact on populations served.
- program-related investments (PRI).
- local chapters of national organizations (the Foundations typically fund initiatives at the national/headquarters level).
- scholarship or fellowship recipients studying or residing outside of the United States
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed November 21, 2023 and last updated November 21, 2023
See 100+ more grants like Hearst Foundations Grants
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Open Applications: Local Community Grants
Wal Mart Foundation
Next deadline: Dec 31, 2023
Later deadlines: Apr 15, 2024, Jul 15, 2024, Oct 15, 2024, Dec 31, 2024
Grant amount: US $250 - US $5,000
Fields of work: Community Development & Revitalization Economic Services & Development Diversity, Equity & Inclusion Academic Success & Enrichment After School /Summer Educational Programs Tutoring & Mentoring Vocational & Trade Education Waste Management Recycling Environmental Stewardship Preventative Healthcare Human & Social Services Supportive Housing & Shelters Food Access & Hunger Community/Public Safety Recreation Arts / Culture Access & Participation Show all
Applicant type: Government Entity, Nonprofit, Indigenous Group, College / University, Elementary / Secondary School, House of Worship (e.g. a church, temple, mosque, etc)
Funding uses: Education / Outreach, General Operating Expense, Project / Program
Location of project: United States
Location of residency: United States
990 Snapshot
Overview:
Walmart’s more than 2 million associates are residents, neighbors, friends and family in thousands of communities around the globe. Walmart works to strengthen these communities through both retail business and community giving, and we support and invest in communities through local giving. The following programs have open application processes with specific deadlines for eligibility and consideration.
Local Community Grants
Each year, our U.S. stores and clubs award local cash grants ranging from $250 to $5,000. These local grants are designed to address the unique needs of the communities where we operate. They include a variety of organizations, such as animal shelters, elder services and community clean-up projects.
Areas of Funding
- There are eight (8) areas of funding for which an organization can apply. Please review the areas listed below to ensure your organization’s goals fall within one of these areas.
- Community and Economic Development: Improving local communities for the benefit of low-income individuals and families in the local service area
- Diversity and Inclusion: Fostering the building of relationships and understanding among diverse groups in the local service area
- Education: Providing afterschool enrichment, tutoring or vocational training for low-income individuals and families in the local service area
- Environmental Sustainability: Preventing waste, increasing recycling, or supporting other programs that work to improve the environment in the local service area
- Health and Human Service: Providing medical screening, treatment, social services, or shelters for low-income individuals and families in the local service area
- Hunger Relief and Healthy Eating: Providing Federal or charitable meals/snacks for low-income individuals and families in the local service area
- Public Safety: Supporting public safety programs through training programs or equipment in the local service area
- Quality of Life: Improving access to recreation, arts or cultural experiences for low-income individuals and families in the local service area
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
Ineligibility:
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed October 03, 2023 and last updated October 03, 2023
See 100+ more grants like Open Applications: Local Community Grants
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Scaife Family Foundation Grant
Scaife Family Foundation
Next predicted deadline: Feb 1, 2024
Later predicted deadlines: Aug 1, 2024, Feb 1, 2025
Grant amount: Unspecified amount
Fields of work: Children’s Health & Pediatrics Children’s Mental Health Child Welfare Services Women's Health Women & Girl Services Human-Animal Interactions & Therapy Family Services Animal Welfare - Domestic Animals & Pets Addiction & Substance Use Disorders Show all
Applicant type: Nonprofit
Funding uses: Project / Program, General Operating Expense
Location of project: Preferred: Counties in Florida: Broward County, Collier County, Miami-Dade County, Monroe County, Palm Beach County, Counties in Pennsylvania: Allegheny County, Armstrong County, Beaver County, Bedford County, Blair County, Butler County, Cambria County, Cameron County, Clarion County, Clearfield County, Crawford County, Elk County, Erie County, Fayette County, Forest County, Greene County, Indiana County, Jefferson County, Lawrence County, McKean County, Mercer County, Somerset County, Venango County, Warren County, Washington County, Westmoreland County Other eligible locations: United States
Location of residency: United States
990 Snapshot
Overview:
NOTE: We have two deadlines for submitting proposals: The first business day in February for our Spring Meeting and the first business day of August for Fall. Submissions should be postmarked on or before either of these two deadlines. We normally only consider grants at our Spring and Fall Meetings, but we accept applications at any time and act upon them as expeditiously as possible.
Scaife Family Foundation Grant
For over 30 years, the most vulnerable members of the community have been supported by the Scaife Family Foundation through charitable funding. Since its inception in 1985, the Foundation has provided more than $150 million in donations for non-profit programs and general operating support.
We aim to help make the world a better place by continuing the legacy of generosity made possible by the Scaife Family. Our primary objective is to match the Foundation with non-profit organizations having similar interest areas and goals.
Mission Statement
The Scaife Family Foundation grant awards will support and develop programs that demonstrate the beneficial interaction between humans and animals, early intervention and prevention in the area of drug and alcohol addiction, and address issues surrounding the health and welfare of women and children.
Funding Priorities
Women and Children
We partner with high-impact organizations that break down barriers and help women and children lead bigger, brighter lives free of violence, addiction or abuse. Among other goals, we promote healthy relationships and social change to support the physical and emotional needs of women and children in crisis.Addiction
Almost 21 million Americans have at least one addiction, yet only 10 percent receive treatment. The most common reasons people don't seek treatment are denial that they have a problem, shame in acknowledging their condition or fear of what treatment and recovery may involve.
We support programs and organizations that eliminate these obstacles and provide addiction prevention, intervention, treatment and recovery. This includes both residential and outpatient facilities that provide additional services like job placement and career counseling.
We also partner with nonprofits who are advancing the field of addiction through research, education and training to help counselors respond more effectively to substance use and related issues. Our funding has also trained thousands of physicians and medical school residents in recognizing and treating addiction, particularly alcoholism.
Animal Welfare
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
- 501(c)3 non-profit organization
Preferences:
- The Foundation's service area is not limited to any particular geographical area within the United States and we will historically consider South Florida and Western Pennsylvania first.
Ineligibility:
- The Foundation will not consider grants to individuals.
- Proposals for the following are usually declined:
- event sponsorships,
- endorsements,
- capital campaigns,
- renovations, or
- government agencies.
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed November 20, 2023 and last updated June 08, 2023
See 100+ more grants like Scaife Family Foundation Grant
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Dr. Scholl Foundation Grants
Dr Scholl Foundation
Deadline: Mar 1, 2024 2:00pm PST (Full proposal)
Grant amount: US $5,000 - US $25,000
Fields of work: Education Environment Community Culture & Heritage Human & Social Services Health Care Access & Delivery Civic Affairs
Applicant type: Nonprofit
Funding uses: Education / Outreach, Project / Program
Location of project: Preferred: United States Other eligible locations: Anywhere in the world
Location of residency: Preferred: United States Other eligible locations: Anywhere in the world
990 Snapshot
Overview:
NOTE:
Application forms must be requested each year online prior to submitting an application. When you submit an LOI, a member of the foundation staff will be contacting you within the next five business days regarding the status of your request.
Full applications are due at the "full proposal" deadline above.
The Foundation is dedicated to providing financial assistance to organizations committed to improving our world. Solutions to the problems of today's world still lie in the values of innovation, practicality, hard work, and compassion.
The Foundation considers applications for grants in the following areas:
- Education
- Social Service
- Health care
- Civic and cultural
- Environmental
The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad to give us flexibility in providing grants.
The majority of our grants are made in the U.S. However, like Dr. Scholl, we recognize the need for a global outlook. Non-U.S. grants are given to organizations where directors have knowledge of the grantee.
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
- The Foundation awards grants on an annual basis to valid Internal Revenue Service 501(c)(3) organizations.
- Funding is primarily given to U.S. applicants.
- We consider funding in countries where a board member has direct knowledge of Non-U.S. applicants.
- Only one application will be accepted from an organization or institution per grant year.
- The Foundation only accepts requests for one year of funding.
Ineligibility:
- The foundation does not consider the following for funding:
- Organizations that do not have a valid IRS 501(c)(3) determination letter
- Organizations that cannot provide us with at least 3 years of financial activity
- Political organizations, political action committees, or individual campaigns whose primary purpose is to influence legislation
- Foundations that are themselves grantmaking bodies
- Grants for loans, operating deficit reductions, the liquidation of a debt or general support
- Grants to individuals
- Grants are rarely made to endowments or capital campaigns
- Event sponsorships including the purchase of tables, tickets or advertisements
- More than one request from the same organization in the same grant cycle
- Publicly supported state, local and federal government organizations (i.e. public schools and municipalities) are rarely considered for grants
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed August 31, 2023 and last updated April 29, 2023
See 100+ more grants like Dr. Scholl Foundation Grants
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Lawrence Foundation Grant
The Lawrence Foundation
Next predicted deadline: Apr 30, 2024 9:59pm PDT (Full proposal)
Later predicted deadlines: Oct 31, 2024 9:59pm PDT (Full proposal)
Grant amount: More than US $5,000
Fields of work: Community Services Environmental Conservation Ecology Environment
Applicant type: Nonprofit
Funding uses: General Operating Expense, Project / Program
Location of project: Anywhere in the world
Location of residency: United States
990 Snapshot
Overview:
The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.
The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.
Grant Amount and Types
Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.
General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
- An applicant must meet the following criteria:
- Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or public schools and libraries are eligible for contributions or grants.
- Engage in work that aligns with the Foundation’s funding interests and priorities.
- To date we have funded organizations that address the following areas of interest:
- Environment (US headquartered organizations operating programs in the US or elsewhere in the world),
- Human Services
- Disaster relief (US headquartered organizations responding to disasters in the US or elsewhere in the world on an occasional basis),
- Other (US headquartered organizations operating programs in the US or elsewhere in the world).
- We are okay if a portion of any grant that we award is used for reasonable indirect costs.
- 50% or lower would be reasonable for indirect costs.
Ineligibility:
- The foundation does not make grants to individuals, international charitable organizations that are not qualified in the US or to for-profit businesses.
- The foundation does not typically make grants for the following purposes.
- Requests to fund the following purposes are likely to be denied:
- Computers or software,
- Audio or video equipment,
- Designing and producing videos, kiosks or promotional material,
- Music programs or musical instruments,
- Gardening programs or equipment,
- Physical education programs or equipment,
- Recreational programs,
- Theater arts or performance arts programs or equipment,
- Hospice or old age home programs,
- Churches,
- Religious, charter or magnet schools
- Individuals for any purpose,
- International organizations that do not have a qualified domestic 501(c)(3) representative,
- Political lobbying activities or other political purposes,
- Voter registration,
- Private foundations,
- Dinners, balls, or other ticketed events,
- Purposes outside of the foundation's funding priorities as listed in the prior section.
- Requests to fund the following purposes are likely to be denied:
- Other than legal requirements, these lists are not absolute and may not always apply, but they provide some guidance about our interests.
- Please also note that Program Related Investments are not currently made.
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed October 25, 2023 and last updated September 09, 2023
See 100+ more grants like Lawrence Foundation Grant
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Max and Victoria Dreyfus Foundation Grant
Max and Victoria Dreyfus Foundation
Next predicted deadline: May 10, 2024 8:59pm PDT
Later predicted deadlines: Nov 10, 2024 8:59pm PST
Grant amount: US $1,000 - US $20,000
Fields of work: Museums & Cultural Institutions Performing Arts Community Culture & Heritage Workforce Preparation & Job Readiness Youth Services Senior Services Disability Care & Services Environmental Conservation Wildlife Management Education - K through 12 Vocational & Trade Education Life Skills Training & Rehabilitation Education - Higher Education Education - Preschool / Early Learning Health Facilities & Clinics Community Services Show all
Applicant type: Nonprofit
Funding uses: General Operating Expense, Project / Program, Education / Outreach
Location of project: United States
Location of residency: United States
990 Snapshot
Overview:
Max and Victoria Dreyfus Foundation Grant
The Foundation will consider requests to support museums, cultural and performing arts programs; schools and hospitals; educational, skills-training and other programs for youth, seniors, and persons with disabilities; environmental and wildlife protection activities; and other community-based organizations and programs.
You can learn more about this opportunity by visiting the funder's website.
Eligibility:
- The Max and Victoria Dreyfus Foundation will consider grants for IRS-qualified non-profit organizations located within the United States.
- The Foundation aims to support organizations and programs for which a relatively small amount of funding might make a large difference.
- Awards typically range from $1,000 to $20,000.
Ineligibility:
- The Foundation cannot make grants to individuals.
The funder insights you need
start your free trial & get a competitive edge
14-day, no-risk trial
Grant Amounts
Easily see the range of award sizes given over time. See key stats such as the most common award size, min/max, and more.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Openness to New Awardees
At a glance, see past and new awardees. See a snapshot over the past three years or dive into individual awards
SAMPLE DATA
For preview purposes only;
not actual funder’s data

Category Insights
Find out funders’ interests by seeing their top giving categories. Drill down into giving patterns per category.
SAMPLE DATA
For preview purposes only;
not actual funder’s data

This page was last reviewed November 17, 2023 and last updated May 21, 2023
See 100+ more grants like Max and Victoria Dreyfus Foundation Grant
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Next deadline: Aug 20, 2024
Later deadlines: Mar 19, 2025
Grant amount: Up to US $450,000
Fields of work: HIV/AIDS Addiction & Substance Use Disorders
Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business
Funding uses: Research
Location of project: Anywhere in the world
Location of residency: Anywhere in the world
Overview:
NOTE: All applications are due by 5:00 PM local time of applicant organization.
We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's
website.
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) (332385)
- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (345845)
- Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
- Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
- Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
- Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
- Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)
- Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) (348813)
- Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (344629)
- Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
- Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
- Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
- Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed)
- Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed)
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) (346137)
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) (346136)
- Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
- Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
- Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
- Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) (351006)
- Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) (349692)
- Alcohol Health Services Research (R01 Clinical Trial Optional) (349812)
- Alcohol Health Services Research (R34 Clinical Trial Optional) (349813)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- Alzheimers Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
- Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) (345351)
- Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)
- Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) (345295)
- Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed)
- Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) (345306)
- Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
- Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) (344128)
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) (344139)
- Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
- Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
- Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)
- Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)
- Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) (350824)
- Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
- Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) (350825)
- Biological Testing Facility (X01 Clinical Trial Not Allowed)
- Biological Testing Facility (X01 Clinical Trial Not Allowed) (347844)
- Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
- Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed)
- Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (350841)
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (350842)
- BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (347532)
- BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (347531)
- BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) (345100)
- BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional)
- BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) (348769)
- BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) (348003)
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
- BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) (347742)
- BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (347256)
- BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) (347500)
- BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed) (351185)
- BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed) (351186)
- BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (350265)
- BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (346912)
- BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) (347547)
- BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) (347764)
- BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) (347763)
- Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) (345272)
- Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) (336070)
- Cancer Immunoprevention Network (CIP-Net) Research Projects (UG3/UH3 Clinical Trials Not Allowed)
- Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) (350415)
- Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed}
- Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) (351136)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
- Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (347437)
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) (349025)
- Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) (349026)
- Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
- Centers for AIDS Research (P30 Clinical Trial Not Allowed) (346745)
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) (347494)
- Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) (348234)
- Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)
- ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) (342124)
- Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)
- Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional)
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) (347497)
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) (347499)
- Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) (340330)
- Cohort Studies of HIV/AIDS and Substance Use (U01 Clinical Trial Not Allowed)
- Co-infection and Cancer (R01 Clinical Trial Not Allowed) (344903)
- Co-infection and Cancer (R21 Clinical Trial Not Allowed) (344904)
- Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) (345794)
- Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) (350603)
- Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) (350493)
- Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)
- Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) (345693)
- Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
- Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed)
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
- Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
- Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) (345706)
- Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
- Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) (346747)
- Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) (347403)
- Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) (347402)
- Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
- Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)
- Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed)
- Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
- Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) (350844)
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)
- Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
- Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) (347398)
- Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
- Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed)
- Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed)
- Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (345098)
- Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
- Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
- Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
- Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
- Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) (348960)
- Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
- Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)
- Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) (345276)
- Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
- Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)
- Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
- Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
- Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
- Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
- Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
- Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) (344439)
- Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) (344440)
- Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
- Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
- Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
- Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) (344572)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (347419)
- Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) (350823)
- Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)
- Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)
- Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
- Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
- Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
- Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)
- Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) (339720)
- Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
- Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
- Genomic Community Resources (U24 Clinical Trial Not Allowed) (346565)
- Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)
- Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (350176)
- Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32) (350978)
- Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) (343339)
- HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
- HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional)
- HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional)
- HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 - Clinical Trial Optional)
- HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
- HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) (347797)
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) (350837)
- HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) (349403)
- HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) (349404)
- HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
- HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
- HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
- Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
- High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
- HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) (344230)
- HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) (348961)
- HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) (348053)
- HIV Prevention and Alcohol (R01 Clinical Trials Optional) (348094)
- HIV Prevention and Alcohol (R34 Clinical Trials Optional) (348090)
- HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) (350461)
- Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
- Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)
- IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
- IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)
- IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) (345987)
- Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
- Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
- Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) (347379)
- Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ) (345394)
- Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
- IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed)
- In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) (345388)
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
- Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
- Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) (345279)
- Initiative for Maximizing Student Development (IMSD) (T32) (350977)
- Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) (347659)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
- Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
- Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
- Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) (345280)
- Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) (345396)
- Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
- Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) (344352)
- Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (345317)
- Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
- International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) (347525)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) (350160)
- Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
- Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) (348051)
- Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
- Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (345365)
- Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
- Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
- Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
- Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
- In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
- Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed) (346991)
- KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
- Laboratories to Optimize Digital Health (R01 Clinical Trial Required) (345270)
- Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
- Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
- Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
- Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
- Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
- Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) (346471)
- Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed)
- Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) (345025)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) (351101)
- Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
- Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) (346134)
- Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
- Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
- Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
- Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
- Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
- Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
- Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) (347654)
- Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) (347656)
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) (344458)
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) (344456)
- Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
- Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
- Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
- Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
- Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed)
- Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed)
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) (345278)
- Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) (345392)
- Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed)
- Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
- Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)
- National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) (349618)
- National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)
- National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)
- National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
- Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
- Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) (348514)
- NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
- NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) (349829)
- NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) (349828)
- NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
- NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
- NCMRR Early Career Research Award (R03 Clinical Trial Optional) (344086)
- NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed) (347865)
- NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
- NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) (348406)
- NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
- NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) (348702)
- NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
- NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)
- NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
- New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
- Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) (348026)
- NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
- NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed) (348508)
- NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) (348507)
- NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) (345301)
- NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) (345300)
- NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (350855)
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) (344643)
- NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (344740)
- NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) (341858)
- NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) (343243)
- NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
- NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) (345149)
- NIDA Program Project Grant Applications (P01 Clinical Trial Optional) (345314)
- NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)
- NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)
- NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
- NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed)
- NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) (345364)
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) (350657)
- NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) (350658)
- NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (351100)
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
- NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
- NIDCR Mentored Career Development Award to Promote Diversity (K01 Clinical Trial Required)
- NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Basic Experimental Studies with Humans Required)
- NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) (347306)
- NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
- NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
- NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) (347177)
- NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
- NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
- NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
- NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
- NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
- NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (348700)
- NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) (347271)
- NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
- NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) (345756)
- NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) (346597)
- NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed) (346599)
- NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed) (346591)
- NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
- NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
- NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
- NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
- NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed) (347055)
- NINDS Program Project Grant (P01 Clinical Trial Optional)
- NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
- NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
- NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (348175)
- NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) (343957)
- Notice of Intent to Publish a Funding Opportunity Announcement for Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Career Enhancement Awards to Advance Research on Firearm Injury and Mortality Prevention
- Notice of Intent to Publish a Funding Opportunity Announcement for Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Model Continuums of Care Initiative (MCCI) to Advance Health Equity Among Women and Girls in Racial/Ethnic Minority and Other Marginalized Communities (U34 Clinical Trials Required)
- Notice of Intent to Publish a Funding Opportunity Announcement for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Notice of Intent to Publish a Funding Opportunity Announcement for Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity for The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
- Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
- Notice of Intent to Publish a Notice of Funding Opportunity for Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (R01 Clinical Trial Required)
- Notice of Intent to Publish the Reissuance of RFA-AG-20-020, Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
- Notice of Intent to Publish the Reissuance of RFA-AG-20-021, Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
- Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) (345385)
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (348712)
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) (348713)
- Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
- Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) (344457)
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) (346505)
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) (346502)
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) (339379)
- Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
- Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
- PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
- Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (345099)
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
- Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) (345395)
- Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
- Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) (339719)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
- Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
- Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) (351106)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (351108)
- Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
- Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
- Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
- Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
- Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
- Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
- Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
- Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
- Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
- Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) (347840)
- Research Program Award (R35 Clinical Trial Optional)
- Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) (349912)
- Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed)
- Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
- Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)
- Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) (351213)
- Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (349876)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (350134)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) (350135)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) (349883)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) (350174)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) (349946)
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) (345619)
- Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) (345437)
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) (349231)
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) (349235)
- Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed) (350046)
- Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) (348997)
- Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) (348995)
- Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) (344666)
- Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
- Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
- Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
- Short Courses to Promote the Broad and Rigorous Use of Common Fund Data (R25 Clinical Trial Not Allowed)
- Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed)
- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R01 Clinical Trial Not Allowed)
- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R21 Clinical Trial Not Allowed)
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
- Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
- Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) (345102)
- Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (349838)
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) (349478)
- Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) (349480)
- Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
- Stimulating Access to Research in Residency (StARR) (R38) (337467)
- Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
- STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
- Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed)
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
- Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (333438)
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
- Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) (350072)
- Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) (350073)
- T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
- Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
- Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
- The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) (344051)
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) (350930)
- The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) (349941)
- Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) (349113)
- Tobacco Regulatory Science (R01 Clinical Trial Optional) (347922)
- Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional)
- Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
- Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
- Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
- Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) (339449)
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
- Translational Neural Devices (U44 Clinical Trial Optional)
- Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) (346550)
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (346551)
- Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
- Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
- Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional)
- Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
- Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (349832)
- Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
- Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
- Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
- Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) (345275)
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) (345391)
- VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)
This page was last reviewed July 24, 2023 and last updated July 24, 2023
See 100+ more grants like Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Next deadline: Aug 20, 2024
Later deadlines: Mar 19, 2025
Grant amount: Up to US $450,000
Fields of work: HIV/AIDS Primary Health Care Addiction & Substance Use Disorders
Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business
Funding uses: Research
Location of project: Anywhere in the world
Location of residency: Anywhere in the world
Overview:
NOTE: All applications are due by 5:00 PM local time of applicant organization.
We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's
website.
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) (332385)
- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (345845)
- Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
- Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
- Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
- Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
- Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)
- Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) (348813)
- Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (344629)
- Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
- Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
- Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
- Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed)
- Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed)
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) (346137)
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) (346136)
- Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
- Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
- Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
- Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) (351006)
- Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) (349692)
- Alcohol Health Services Research (R01 Clinical Trial Optional) (349812)
- Alcohol Health Services Research (R34 Clinical Trial Optional) (349813)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- Alzheimers Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
- Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) (345351)
- Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)
- Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) (345295)
- Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed)
- Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) (345306)
- Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
- Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) (344128)
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) (344139)
- Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
- Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
- Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)
- Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)
- Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) (350824)
- Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
- Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) (350825)
- Biological Testing Facility (X01 Clinical Trial Not Allowed)
- Biological Testing Facility (X01 Clinical Trial Not Allowed) (347844)
- Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
- Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed)
- Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (350841)
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (350842)
- BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (347532)
- BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (347531)
- BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) (345100)
- BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional)
- BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) (348769)
- BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) (348003)
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
- BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) (347742)
- BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (347256)
- BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) (347500)
- BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed) (351185)
- BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed) (351186)
- BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (350265)
- BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (346912)
- BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) (347547)
- BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) (347764)
- BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) (347763)
- Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) (345272)
- Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) (336070)
- Cancer Immunoprevention Network (CIP-Net) Research Projects (UG3/UH3 Clinical Trials Not Allowed)
- Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) (350415)
- Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed}
- Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) (351136)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
- Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (347437)
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) (349025)
- Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) (349026)
- Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
- Centers for AIDS Research (P30 Clinical Trial Not Allowed) (346745)
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) (347494)
- Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) (348234)
- Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)
- ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) (342124)
- Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)
- Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional)
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) (347497)
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) (347499)
- Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) (340330)
- Cohort Studies of HIV/AIDS and Substance Use (U01 Clinical Trial Not Allowed)
- Co-infection and Cancer (R01 Clinical Trial Not Allowed) (344903)
- Co-infection and Cancer (R21 Clinical Trial Not Allowed) (344904)
- Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) (345794)
- Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) (350603)
- Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) (350493)
- Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)
- Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) (345693)
- Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
- Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed)
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
- Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
- Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) (345706)
- Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
- Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) (346747)
- Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) (347403)
- Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) (347402)
- Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
- Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)
- Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed)
- Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
- Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) (350844)
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)
- Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
- Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) (347398)
- Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
- Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed)
- Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed)
- Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (345098)
- Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
- Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
- Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
- Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
- Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) (348960)
- Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
- Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)
- Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) (345276)
- Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
- Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)
- Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
- Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
- Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
- Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
- Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
- Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) (344439)
- Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) (344440)
- Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
- Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
- Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
- Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) (344572)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (347419)
- Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) (350823)
- Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)
- Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)
- Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
- Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
- Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
- Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)
- Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) (339720)
- Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
- Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
- Genomic Community Resources (U24 Clinical Trial Not Allowed) (346565)
- Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)
- Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (350176)
- Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32) (350978)
- Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) (343339)
- HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)
- HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
- HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional)
- HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional)
- HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 - Clinical Trial Optional)
- HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
- HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) (347797)
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) (350837)
- HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) (349403)
- HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) (349404)
- HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
- HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
- HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
- Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
- High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
- HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) (344230)
- HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) (348961)
- HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) (348053)
- HIV Prevention and Alcohol (R01 Clinical Trials Optional) (348094)
- HIV Prevention and Alcohol (R34 Clinical Trials Optional) (348090)
- HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) (350461)
- Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
- Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)
- IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
- IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)
- IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) (345987)
- Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
- Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
- Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) (347379)
- Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ) (345394)
- Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
- IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed)
- In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) (345388)
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
- Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
- Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) (345279)
- Initiative for Maximizing Student Development (IMSD) (T32) (350977)
- Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) (347659)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
- Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
- Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
- Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) (345280)
- Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) (345396)
- Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
- Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) (344352)
- Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (345317)
- Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
- International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) (347525)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) (350160)
- Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
- Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) (348051)
- Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
- Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (345365)
- Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
- Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
- Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
- Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
- In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
- Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed) (346991)
- KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
- Laboratories to Optimize Digital Health (R01 Clinical Trial Required) (345270)
- Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
- Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
- Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
- Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
- Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
- Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) (346471)
- Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed)
- Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) (345025)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) (351101)
- Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
- Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) (346134)
- Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
- Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
- Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
- Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
- Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
- Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
- Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
- Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) (347654)
- Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) (347656)
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) (344458)
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) (344456)
- Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
- Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
- Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
- Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
- Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed)
- Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed)
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) (345278)
- Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) (345392)
- Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed)
- Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
- Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)
- National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) (349618)
- National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)
- National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)
- National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
- Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
- Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) (348514)
- NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
- NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) (349829)
- NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) (349828)
- NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
- NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
- NCMRR Early Career Research Award (R03 Clinical Trial Optional) (344086)
- NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed) (347865)
- NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
- NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) (348406)
- NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
- NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) (348702)
- NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
- NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)
- NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
- New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
- Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) (348026)
- NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
- NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed) (348508)
- NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) (348507)
- NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) (345301)
- NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) (345300)
- NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (350855)
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) (344643)
- NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (344740)
- NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) (341858)
- NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) (343243)
- NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
- NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) (345149)
- NIDA Program Project Grant Applications (P01 Clinical Trial Optional) (345314)
- NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)
- NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)
- NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
- NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed)
- NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) (345364)
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) (350657)
- NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) (350658)
- NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (351100)
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
- NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
- NIDCR Mentored Career Development Award to Promote Diversity (K01 Clinical Trial Required)
- NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Basic Experimental Studies with Humans Required)
- NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) (347306)
- NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
- NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
- NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) (347177)
- NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
- NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
- NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
- NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
- NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
- NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (348700)
- NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) (347271)
- NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
- NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) (345756)
- NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) (346597)
- NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed) (346599)
- NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed) (346591)
- NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
- NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
- NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
- NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
- NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed) (347055)
- NINDS Program Project Grant (P01 Clinical Trial Optional)
- NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
- NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
- NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (348175)
- NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) (343957)
- Notice of Intent to Publish a Funding Opportunity Announcement for Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Career Enhancement Awards to Advance Research on Firearm Injury and Mortality Prevention
- Notice of Intent to Publish a Funding Opportunity Announcement for Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Model Continuums of Care Initiative (MCCI) to Advance Health Equity Among Women and Girls in Racial/Ethnic Minority and Other Marginalized Communities (U34 Clinical Trials Required)
- Notice of Intent to Publish a Funding Opportunity Announcement for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Notice of Intent to Publish a Funding Opportunity Announcement for Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity for The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
- Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
- Notice of Intent to Publish a Notice of Funding Opportunity for Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (R01 Clinical Trial Required)
- Notice of Intent to Publish the Reissuance of RFA-AG-20-020, Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
- Notice of Intent to Publish the Reissuance of RFA-AG-20-021, Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
- Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) (345385)
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (348712)
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) (348713)
- Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
- Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) (344457)
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) (346505)
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) (346502)
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) (339379)
- Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
- Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
- PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
- Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (345099)
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
- Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) (345395)
- Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
- Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) (339719)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
- Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
- Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) (351106)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (351108)
- Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
- Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
- Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
- Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
- Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
- Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
- Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
- Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
- Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
- Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) (347840)
- Research Program Award (R35 Clinical Trial Optional)
- Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) (349912)
- Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed)
- Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
- Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)
- Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) (351213)
- Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (349876)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (350134)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) (350135)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) (349883)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) (350174)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) (349946)
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) (345619)
- Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) (345437)
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) (349231)
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) (349235)
- Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed) (350046)
- Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) (348997)
- Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) (348995)
- Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) (344666)
- Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
- Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
- Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
- Short Courses to Promote the Broad and Rigorous Use of Common Fund Data (R25 Clinical Trial Not Allowed)
- Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed)
- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R01 Clinical Trial Not Allowed)
- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R21 Clinical Trial Not Allowed)
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
- Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
- Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) (345102)
- Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (349838)
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) (349478)
- Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) (349480)
- Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
- Stimulating Access to Research in Residency (StARR) (R38) (337467)
- Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
- STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
- Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed)
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
- Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (333438)
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
- Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) (350072)
- Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) (350073)
- T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
- Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
- Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
- The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) (344051)
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) (350930)
- The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) (349941)
- Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) (349113)
- Tobacco Regulatory Science (R01 Clinical Trial Optional) (347922)
- Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional)
- Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
- Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
- Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
- Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) (339449)
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
- Translational Neural Devices (U44 Clinical Trial Optional)
- Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) (346550)
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (346551)
- Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
- Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
- Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional)
- Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
- Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (349832)
- Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
- Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
- Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
- Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) (345275)
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) (345391)
- VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)
This page was last reviewed October 15, 2023 and last updated October 05, 2023
See 100+ more grants like Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
We have 10,000+ more grants for you. Find out which ones are good fits for your nonprofit.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”
Like what you saw?
We have 10,000+ more grants for you.
Create your 14-day free account to find out which ones are good fits for your nonprofit.
Not ready yet? Browse more grants.

Grants Manager
KVC Health Systems
“Through Instrumentl, I was able to accomplish in 6 hours...SIX HOURS...what would have taken days or weeks with [another] search engine.”